Almost one year ago, Brazilian president Lula da Silva assembled the first South American summit in nearly a decade to gather the continent’s nations onto a single forum to encourage pharmaceutical trade. In this month’s cover story, we take a look at the progress made since then and identify the main priorities for the public and private pharma sectors in South America.

Recommended Buyer's Guides

Also in this issue, we continue to follow the opioid crisis in the US, by understanding the nature of the multibillion dollar settlements made by companies implicated in the crisis to several state governments. Now that the legal settlements have been finalised, the next question remains on how to distribute these funds in the best way possible to address the ongoing challenges with those suffering from opioid use disorder.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Don’t miss coverage on the burgeoning cell and gene therapy landscape in the US, the challenges with sham patents, and much more.

Supplement: ESG in pharma

We also have an entire supplement dedicated to ESG in this issue, where we investigate the latest driving forces in ESG, look at sponsors are addressing the sustainability question for clinical trials in rare diseases, how climate change could impact the spread of infectious diseases across the world, and more through features, interviews and analyst commentary.

All this and the latest news and analysis on the pharmaceutical and biotech industry.

See Also:

Read the latest issue of Pharma Technology Focus for all this and insights, and analysis from the pharmaceutical industry

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

You can also subscribe here to receive email notifications when a new issue is available.